Please login to the form below
Wave
This page shows the latest Wave news and features for those working in and with pharma, biotech and healthcare.
Troubled Alkermes eyes November OK for new antipsychotic
The project has since been dropped, and its demise prompted a wave of job cuts at the loss-making biotech later in 2019 in an effort to slash $150m off its
Latest news
-
The digital shift in pharma marketing
Furthermore, the emergence of artificial intelligence and machine learning applications unveiled the extent to which technology could unleash a new wave of customer engagement in a meaningful, outcome-oriented manner.
-
Wave’s challenge to Sarepta in Duchenne falls flat
Shares in the company down more than 50%. Wave Life Sciences has abandoned two drugs for Duchenne muscular dystrophy, including phase 2/3 candidate suvodirsen, in a move that takes the ... The demise of Wave’s programmes leaves Japan’s Nippon
-
NHS plans to cut certain routine tests as part of cost-saving efforts
Kidney stones would also be treated differently with sound wave therapy rather than surgery removal, according to the report.
-
Takeda highlights 12 NMEs with $10bn-plus sales potential at R&D day
That first wave of new molecular entities (NMEs) has the potential to generate 14 approvals and collectively add more than $10bn in aggregate peak sales, according to R&D chief Andy ... The 12 NMEs – all said to be either first- or best-in-class –
-
AZ reports growth again in Q3, driven by oncology and China sales
In particular, Farxiga has been making waves as AZ has continued to add on extra indications for the SGLT2 inhibitor as it stakes a bigger claim in heart failure, including a
More from news
Approximately 2 fully matching, plus 228 partially matching documents found.
Latest Intelligence
-
20 for 2020 – Five pharma companies to watch
wave of products intended to reduce its reliance on Humira, starting in 2020.
-
Case study: Ovarian Cancer Action (OCA)
Former Prime Minister Theresa May joined many colleagues in wearing a white rose during Prime Minister’s questions, prompting a second wave in social media and press activity.
-
The transatlantic opioid crisis
The Oklahoma ruling will have emboldened many others across the US and has sparked speculation on this side of the Atlantic that a wave of litigation may come crashing over the
-
As the opioid crisis grabs the headlines, the search for safe treatments continues
Four major pharmaceutical companies recently agreed to pay $260m to settle the first wave of actions in the US, with some experts predicting final bills of around $50bn across the industry.
-
A snapshot of Microbiotica
Cambridge, UK-based Microbiotica is part of a new wave of pioneering firms focused on developing novel therapeutics based on the microbiome – the bacteria which live in the human body and
More from intelligence
Approximately 0 fully matching, plus 66 partially matching documents found.
Latest appointments
-
Trio of new starters for Wave
Pictured from left: Lucy Noble, Ella Withey and Maria Cain. UK medical education company Wave has boosted its editorial and programme delivery teams with three new appointments. ... Wave has appointed Ella Withey as an editorial assistant, with 18 months
-
WE UK appoints Catherine Devaney as head of health
Joining a team of communications professionals based in London, Devaney’s appointment is the latest in a wave of new hires for the group.
-
Two new starters boost Wave’s senior team
Sadaf Kazi and Dr Florentia Loizou join the group. Specialist medical education company Wave has appointed Sadaf Kazi and Dr Florentia Loizou (pictured right) as editor and senior programme executive, respectively. ... James Seed, co-owner and director
-
Wave strengthens programme delivery team
Dr Andrea Hamlin and Aashni Shah joins firm. Specialist medical education company Wave has appointed two senior hires to support its growing client base. ... Roderick Ball, co-owner and director of Wave, said: “We are delighted that Andrea and Aashni
-
e-Therapeutics appoints new CEO
He said: “e-therapeutics is at the forefront of a new wave of science and has created a unique, computational-based drug discovery platform.
More from appointments
Approximately 8 fully matching, plus 8 partially matching documents found.
Latest from PMHub
-
Qualitative segmentation validation study with backroom brainstorm exercises
In an earlier quantitative wave of research we had identified four segments to define physician treatment and prescription behaviors.
-
Learning about Rare Genetic Disorders on Undiagnosed Children’s Day
Stay tuned for progress updates. One field of research has been making waves in this area of extremely rare disorders, shifting Exome Sequencing into the dark ages.
-
Saving Time
If we are to sail through the waves of this ultra-high-tech world, it is vital that we avoid slipping into a laggard mentality and keep pace with the latest
-
Bedrock creates waves
The Bedrock team were awash with ideas at their summer watersports and BBQ event. All were Bravely Bedrock in a host of activities – including wakeboarding, paddle boarding and taming the infamous Ringo Rides! The annual event provides colleagues
-
Three strategies for managing loss of exclusivity successfully
Patent losses could sink Allergan”. “Drug prices to plummet in wave of expiring patents”.
More from PMHub
Approximately 0 fully matching, plus 27 partially matching documents found.
Featured jobs
-
Account Manager (PR)
-
Great Benefits
- Digital Associate Director - Medcomms
-
£65000 - £80000 per annum
-
Account director
-
Competitive salary and bonus scheme
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Publications director
-
Competitive salary and bonus scheme
- Account Director, Healthcare Communications
-
Salary TBC
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
-
Account Director, Medical Education
-
Salary TBC
-
Experienced medical editor
-
Competitive salary and bonus scheme
- Account Manager, Healthcare Communications
-
£32, 000 - £40, 000 bonus benefits
-
Account Director
-
£Competitive Salary
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
-
Scientific Director
-
£60000 - £85000 per annum, Benefits: Bonus, pension, subsidised gym and much more
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
-
Senior External Communications Lead
-
£Competitive Salary
Subscribe to our email news alerts
- Novo Nordisk awakens its ‘Sleeping Beauty’
- AbbVie/Allergan merger faces renewed public opposition despite divestments
- Genital herpes vaccine candidate heads for human studies
- Categories - Communiqué Awards
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Bayer shares dip as Novartis gets EU okay for Beovu in wet AMD
- Introducing Nucleus POLAR™, a state-of-the-art external expert search engine and engagement management tool
- GSK pays $50m upfront to tap Immatics’ cell therapy platform
- Researchers discover new antibiotic using AI
- Bedrock Group celebrates a trio of new hires
- Tocagen merges with Forte Biosciences after brain cancer fail
- Immutep spikes on trial of its LAG-3 drug with Keytruda
PMHub
Real Science Communications
Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...
Latest intelligence
- Novo Nordisk awakens its ‘Sleeping Beauty’
- Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
- How will the Tories’ historic win shape the NHS?
- Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
- CSR 'Christmas Spirit' 2019
- OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...
Quick links
Infographics
